Abstract
There is an increasing clinical challenge in the treatment of primary and secondary brain tumors, mostly because of a rise in the number of patients with brain metastases and the limited treatment results with the standard treatments available today. A novel and promising treatment modality, electrochemotherapy, which is a combination of the technique of electroporation and the chemotherapeutic drug bleomycin, could be a new treatment option for these patients. This chapter elucidates the background and experience with electrochemotherapy and looks into the possibilities for use in the treatment of primary and secondary brain tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AbdelWahab MMR, Wolfson AH, Raub W, Landy H, Feun L, Sridhar K, Brandon AH, Mahood S, Markoe AM (1997) The role of hyperfractionated re-irradiation in metastatic brain disease – a single institutional trial. Am J Clin Oncol 20:158–160
Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, Gehl J (2011) Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 71:3753–3762
Bokemeyer C (2008) Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens? J Clin Oncol 26:1783–1785
Cooper JS, Steinfeld AD, Lerch IA (1990) Cerebral metastases – value of reirradiation in selected patients. Radiology 174:883–885
De Angelis LM, Yahalom J (1993) Lymphomas. In: De Vita V, Hellmann S, Rosenberg S (eds) Cancer, principles and practice of oncology, 5th edn. Lippincott-Raven Publishers, Philadelphia, p 2237
Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J (2012) Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 72:1336–1341
Gehl J (2003) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177:437–447
Gehl J, Skovsgaard T, Mir LM (1998) Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 9:319–325
Gori S, Rimondini S, De Angelis V, Colozza M, Bisagni G, Moretti G, Sidoni A, Basurto C, Aristei C, Anastasi P, Crino L (2007) Central nervous system metastases in HER-2-positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors. Oncologist 12:766–773
Gothelf A, Mir LM, Gehl J (2003) Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 29:371–387
Hazuka MB, Kinzie JJ (1988) Brain metastases – results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 15:433–437
Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, Glass LF (1998) Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 83:148–157
Hojman P, Gissel H, Andre FM, Cournil-Henrionnet C, Eriksen J, Gehl J, Mir LM (2008) Physiological effects of high- and Low-voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther 19:1249–1260
Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R (2000) Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 11:201–208
Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ (1994) Mri evaluation Op solitary brain metastases with triple-dose gadoteridol – comparison with contrast-enhanced Ct and conventional-dose gadopentetate dimeglumine Mri studies in the same patients. Comput Med Imaging Graph 18:391–399
Kurup P, Reddy S, Hendrickson FR (1980) Results of re-irradiation for cerebral metastases. Cancer 46:2587–2589
Lazo J, Chabner B (1996) Bleomycin. In: Cancer chemotherapy and biotherapy, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 379–393
Li J, Bentzen SM, Renschler M, Mehta MP (2007) Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25:1260–1266
Linnert M, Gehl J (2009) Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs 20:157–164
Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, Billard V, Geertsen PF, Larkin JO, Miklavcic D, Pavlovic I, Paulin-Kosir SM, Cemazar M, Morsli N, Rudolf Z, Robert C, O’Sullivan GC, Mir LM (2006) Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supplements 4:3–13
Matthiessen LW, Johannesen HH, Hendel HW, Moss T, Kamby C, Gehl J (2012) Electrochemotherapyfor large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 51:713–721
Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165
Mir LM, Tounekti O, Orlowski S (1996) Bleomycin: revival of an old drug. Gen Pharmacol 27:745–748
Neuwelt EA (2004) Mechanisms of disease: the blood-brain barrier. Neurosurgery 54:131–140
Orlowski S, Belehradek J Jr, Paoletti C, Mir LM (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37:4727–4733
Poddevin B, Orlowski S, Belehradek J, Mir LM (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42:S67–S75
Ryberg M, Nielsen D, Osterlind K, Andersen PK, Skovsgaard T, Dombernowsky P (2005) Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy. Breast Cancer Res Treat 91:217–225
Sadikov E, Bezjak A, Yi QL, Wells W, Dawson L, Millar BA, Laperriere N (2007) Value of whole brain re-irradiation for brain metastases – single centre experience. Clin Oncol 19:532–538
Salford LG, Persson BR, Brun A, Ceberg CP, Kongstad PC, Mir LM (1993) A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 194:938–943
Saulis G, Venslauskas MS, Naktinis J (1991) Kinetics of pore resealing in cell-membranes after electroporation. Bioelectrochem Bioenerg 26:1–13
Shehata WM, Hendrick FR, Hindo WA (1974) Rapid fractionation technique and retreatment of cerebral metastases by irradiation. Cancer 34:257–261
Siesjo P, Visse E, Lindvall M, Salford L, Sjogren HO (1993) Immunization with mutagen-treated (tum-) cells causes rejection of nonimmunogenic rat glioma isografts. Cancer Immunol Immunother 37:67–74
Smedby KE, Brandt L, Backlund ML, Blomqvist P (2009) Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 101:1919–1924
Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514
Teissie J, Rols MP (1993) An experimental evaluation of the critical potential difference inducing cell-membrane electropermeabilization. Biophys J 65:409–413
Tounekti O, Kenani A, Foray N, Orlowski S, Mir LM (2001) The ratio of single- to double-strand DNA breaks and their absolute values determine cell death pathway. Br J Cancer 84:1272–1279
Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 19:200–209
Videtic GM, Gaspar LE, Aref AM, Germano IM, Goldsmith BJ, Imperato JP, Marcus KJ, McDermott MW, McDonald MW, Patchell RA, Robins HI, Rogers CL, Suh JH, Wolfson AH, Wippold FJ (2009) American college of radiology appropriateness criteria on multiple brain metastases. Int J Radiat Oncol Biol Phys 75:961–965
Wong WW, Schild SE, Sawyer TE, Shaw EG (1996) Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34:585–590
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Linnert, M., Agerholm-Larsen, B., Mahmood, F., Iversen, H.K., Gehl, J. (2014). Treatment of Brain Tumors: Electrochemotherapy. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 12. Tumors of the Central Nervous System, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7217-5_22
Download citation
DOI: https://doi.org/10.1007/978-94-007-7217-5_22
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7216-8
Online ISBN: 978-94-007-7217-5
eBook Packages: MedicineMedicine (R0)